Evaluation of  GeMa CerMat Program  During The Peak of COVID-19 Pandemic in Indonesia

Didiek Hardiyanto Soegiantoro; Holy Rhema Soegiantoro; Gregory Hope Soegiantoro

doi:10.29241/jmk.v8i1.942

Evaluation of GeMa CerMat Program During The Peak of COVID-19 Pandemic in Indonesia

DOI: 10.29241/jmk.v8i1.942

Author

Didiek Hardiyanto Soegiantoro⁽¹⁾, Holy Rhema Soegiantoro⁽²⁾, Gregory Hope Soegiantoro⁽³⁾,
(1) Universitas Kristen Immanuel
(2) IPMI International Business School, Jakarta
(3) Padmanaba 3rd State Senior High School Yogyakarta

Corresponding Author

Full Text

Full Text: View / Download PDF

Article Metrics

Abstract View

: 302 times; PDF

Download : 264 times

Abstract

The GeMa CerMat program from the Indonesian Ministry of Health was started in 2015 with the aim of rational drug use. The success of GeMa CerMat's goal in rational use of drugs was tested by the COVID-19 pandemic which reached its peak in June to August 2021. Public panic due to the high death rate of COVID-19 caused panic buying for drugs used in the treatment of COVID-19, including prescribed drugs. The demand for COVID-19 prescribed drugs without prescription describes the irrational use of drugs and an uncontrolled increase in demand that will lead to a shortage of drugs in distribution channels and increase the cost of purchase according to the theory of supply and demand. This study is an observational study using a cross-sectional analysis method from a number of pharmacies in each region, conducted from June to August 2021. The results showed an increase more than 2 times in demand for prescribed drugs without prescription for COVID-19 drugs, which resulted in an increase in purchasing lead times more than 3 times, as well as an increase in the cost of purchase of drugs more than 3 times and could be controlled with government selling price standard. The conclusion of this study is that the GeMa CerMat program has not succeeded in educating the public to use drugs rationally, as a result, during the peak of the COVID-19 pandemic, panic buying occurred for COVID-19 prescribed drugs which resulted in an increase in purchasing lead time and cost of purchase.

Keywords

rational drug use, purchasing lead time, cost of purchase, COVID-19, pharmacies

References

Aravamuthan, A., Arputhavanan, M., Subramaniam, K., & Udaya Chander J, S. J. (2016). Assessment of current prescribing practices using World Health Organization core drug use and complementary indicators in selected rural community pharmacies in Southern India. Journal of Pharmaceutical Policy and Practice, 10(1), 1. https://doi.org/10.1186/s40545-016-0074-6

Derqui, B., Filimonau, V., & Matute, J. (2021). Assessing the scale of adoption of sustainability practices by community pharmacies in Spain in the time of COVID-19. Sustainable Production and Consumption, 27, 1626–1636. https://doi.org/10.1016/j.spc.2021.03.034

Hayden, J. C., & Parkin, R. (2020). The challenges of COVID-19 for community pharmacists and opportunities for the future. Irish Journal of Psychological Medicine, 37(3), 198–203. https://doi.org/10.1017/ipm.2020.52

Kementerian Kesehatan R.I. (n.d.). Buku Saku Protokol Tata Laksana Covid-19. Direktorat Promosi Kesehatan Kementerian Kesehatan RI. Retrieved December 9, 2021, from https://promkes.kemkes.go.id/buku-saku-protokol-tata-laksana-covid-19

Komala, L., Komariah, K., Novianti, E., Subekti, P., & Lukman, S. (2019). Utilizing social media for socialization of gema cermat program by public health office of west java indonesia. Journal of Physics: Conference Series, 1175, 012233. https://doi.org/10.1088/1742-6596/1175/1/012233

Lima, M. G., Álvares, J., Guerra, A. A., Costa, E. A., Guibu, I. A., Soeiro, O. M., Leite, S. N., Karnikowski, M. G. de O., Costa, K. S., & Acurcio, F. de A. (2017). Indicators related to the rational use of medicines and its associated factors. Revista de Saúde Pública, 51. https://doi.org/10.11606/S1518-8787.2017051007137

Lin, Z.-J., & Zhang, B. (2020). Strategy of pharmaceutical care services for clinical Chinese pharmacists in coronavirus disease 2019 (COVID-19). Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 45(6), 1259–1262. https://doi.org/10.19540/j.cnki.cjcmm.20200211.501

Liu, S., Luo, P., Tang, M., Hu, Q., Polidoro, J. P., Sun, S., & Gong, Z. (2020). Providing pharmacy services during the coronavirus pandemic. International Journal of Clinical Pharmacy, 42(2), 299–304. https://doi.org/10.1007/s11096-020-01017-0

Lopes, C. C. C., Silva, H. de Q. e, Lopes, E. B., & Ammar, Y. E. (2021). Pharmaceutical Conduct Applied to Pharmacies During the Sars Cov2 Pandemic (Covid-19). 8(8). https://ijaers.com/detail/pharmaceutical-conduct-applied-to-pharmacies-during-the-sars-cov2-pandemic-covid-19/

Mursiti, H., Embri, G. M., Prasanti, A., Maysha, A., Rosvita, V., Bashori, Y. M., & Farida, Y. (2020). Optimalisasi Penggunaan Obat yang Bijak dalam Keluarga dengan Program Gema Cermat. Pharmacon: Jurnal Farmasi Indonesia, 0, 21–28. https://doi.org/10.23917/pharmacon.v0i0.10106

Narendrakumar, L., Joseph, I., & Thomas, S. (2021). Potential effectiveness and adverse implications of repurposing doxycycline in COVID-19 treatment. Expert Review of Anti-Infective Therapy, 19(8), 1001–1008. https://doi.org/10.1080/14787210.2021.1865803

Sharif, N., & Dey, S. K. (2021). Impact of population density and weather on COVID-19 pandemic and SARS-CoV-2 mutation frequency in Bangladesh. Epidemiology & Infection, 149. https://doi.org/10.1017/S0950268821000029

Sisay, M., Mengistu, G., Molla, B., Amare, F., & Gabriel, T. (2017). Evaluation of rational drug use based on World Health Organization core drug use indicators in selected public hospitals of eastern Ethiopia: A cross sectional study. BMC Health Services Research, 17(1), 161. https://doi.org/10.1186/s12913-017-2097-3